Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The results showed that patients with trebananib treatment had a significantly longer median PFS compared to patients with placebo treatment (7.2 months compared to 5.4 months)
All handling, measuring, formulation blending, and experimental evaluation must be conducted exclusively by qualified scientific professionals within a certified and monitored research facility
The proposal is reviewed by a committee and typically awardees are notified and funded within 4 to 6 months
Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress
Myo-inositol effects in women with PCOS: A meta-analysis of randomized controlled trials
Moreover, dispersed GO nanoparticles exhibit low viscosity and cytotoxicity at high concentrations, thereby making them good candidates for local administration
US$ 24.69
US$ 25.20
US$ 20.25
US$ 28.32
